440
Participants
Start Date
December 1, 2025
Primary Completion Date
July 31, 2029
Study Completion Date
July 31, 2029
AADvac1
Active immunotherapy
Treatment B
Tau-directed, neuroprotective or other therapy
Collaborators (1)
National Institute on Aging (NIA)
NIH
Alzheimer's Therapeutic Research Institute
OTHER
University of Southern California
OTHER
Massachusetts General Hospital
OTHER
University of California, San Diego
OTHER
Alzheimer's Clinical Trials Consortium
OTHER
Adam Boxer
OTHER